High rates of resistance to colistin and polymyxin B in subgroups of Acinetobacter baumannii isolates from Korea

被引:196
|
作者
Ko, Kwan Soo
Suh, Ji Yoeun
Kwon, Ki Tae
Jung, Sook-In
Park, Kyong-Hwa
Kang, Cheol In
Chung, Doo Ryeon
Peck, Kyong Ran
Song, Jae-Hoon
机构
[1] Sungkyunkwan Univ, Samsung Med Ctr, Div Infect Dis, Seoul 135710, South Korea
[2] Sungkyunkwan Univ, Sch Med, Dept Mol Cell Biol, Suwon, South Korea
[3] Asian Pacific Res Fdn Infect Dis ARFID, Seoul 135710, South Korea
[4] Daegu Fatima Hosp, Div Infect Dis, Taegu, South Korea
[5] Chonnam Natl Univ, Sch Med, Kwangju, South Korea
关键词
rpoB; antimicrobial resistance; subgrouping;
D O I
10.1093/jac/dkm305
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Objectives: To investigate antimicrobial resistance in clinical isolates of Acinetobacter spp. from two Korean hospitals. Methods: Two hundred and sixty-five isolates of Acinetobacter spp. from two Korean hospitals were collected and were identified to species level using partial rpoB gene sequences. Antimicrobial susceptibility testing was performed using a broth microdilution method. Results: rpoB gene sequences indicated that 214 isolates (80.8%) were Acinetobacter baumannii, and allowed these to be classified into three subgroups (I, II and III); 142 isolates (53.6%) belonged to subgroup I, 54 (20.4%) to subgroup II and 18 (6.8%) to subgroup III. Forty-eight isolates (18.1%) and 74 isolates (27.9%) were resistant to polymyxin B and colistin, respectively. However, antimicrobial resistance rates varied markedly between subgroups. While A. baumannii subgroup I showed low resistance rates to polymyxin B and colistin (2.1% and 7.0%, respectively), subgroups II and III showed high resistance rates to these antibiotics (38.9% and 64.8% in subgroup II and 72.2% and 88.9%, in subgroup III, respectively). Multidrug resistance was also significantly more frequent in subgroup I (45.1%) than in subgroups II and III (13.0% and 16.7%, respectively). Conclusions: Our data indicate that subgroup identification of A. baumannii may aid selection of appropriate antimicrobial agents for the treatment of Acinetobacter infections.
引用
收藏
页码:1163 / 1167
页数:5
相关论文
共 50 条
  • [21] In vitro pharmacodynamics of colistin against Acinetobacter baumannii clinical isolates
    Owen, Roxanne J.
    Li, Jian
    Nation, Roger L.
    Spelman, Denis
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2007, 59 (03) : 473 - 477
  • [22] Detection of colistin sensitivity in clinical isolates of Acinetobacter baumannii in Iran
    Vakili, Bahareh
    Fazeli, Hossein
    Shoaei, Parisa
    Yaran, Majid
    Ataei, Behrooz
    Khorvash, Farzin
    Khaleghi, Moj
    JOURNAL OF RESEARCH IN MEDICAL SCIENCES, 2014, 19 : S67 - S70
  • [23] Sub-minimum inhibitory concentrations of colistin and polymyxin B promote Acinetobacter baumannii biofilm formation
    Sato, Yoshinori
    Unno, Yuka
    Ubagai, Tsuneyuki
    Ono, Yasuo
    PLOS ONE, 2018, 13 (03):
  • [24] A novel decoy strategy for polymyxin resistance in Acinetobacter baumannii
    Park, Jaeeun
    Kim, Misung
    Shin, Bora
    Kang, Mingyeong
    Yang, Jihye
    Lee, Tae Kwon
    Park, Woojun
    ELIFE, 2021, 10
  • [25] RapidResa Polymyxin Acinetobacter NP(R) Test for Rapid Detection of Polymyxin Resistance in Acinetobacter baumannii
    Bouvier, Maxime
    Sadek, Mustafa
    Pomponio, Stefano
    D'Emidio, Fernando
    Poirel, Laurent
    Nordmann, Patrice
    ANTIBIOTICS-BASEL, 2021, 10 (05):
  • [26] High rate of colistin dependence in Acinetobacter baumannii
    Hong, Yoon-Kyoung
    Lee, Ji-Young
    Wi, Yu Mi
    Ko, Kwan Soo
    JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 2016, 71 (08) : 2346 - 2348
  • [27] Reliability of the E-test method for detection of colistin resistance in clinical isolates of Acinetobacter baumannii
    Arroyo, LA
    García-Curiel, A
    Pachón-Ibañez, ME
    Llanos, AC
    Ruiz, M
    Pachón, J
    Aznar, J
    JOURNAL OF CLINICAL MICROBIOLOGY, 2005, 43 (02) : 903 - 905
  • [28] Evaluation of resazurin-based rapid test to detect colistin resistance in Acinetobacter baumannii isolates
    Julija Germ
    Laurent Poirel
    Tjasa Cerar Kisek
    Vesna Cvitkovic Spik
    Katja Seme
    Manica Mueller Premru
    Tatjana Lejko Zupanc
    Patrice Nordmann
    Mateja Pirs
    European Journal of Clinical Microbiology & Infectious Diseases, 2019, 38 : 2159 - 2162
  • [29] Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii
    Gerson, Stefanie
    Lucassen, Kai
    Wille, Julia
    Nodari, Carolina S.
    Stefanik, Danuta
    Nowak, Jennifer
    Wille, Thorsten
    Betts, Jonathan W.
    Roca, Ignasi
    Vila, Jordi
    Cisneros, Jose M.
    Seifert, Harald
    Higgins, Paul G.
    INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS, 2020, 55 (03)
  • [30] Prevalence of colistin resistance in clinical isolates of Acinetobacter baumannii: a systematic review and meta-analysis
    Narjess Bostanghadiri
    Negar Narimisa
    Maryam Mirshekar
    Leila Dadgar-Zankbar
    Elahe Taki
    Tahereh Navidifar
    Davood Darban-Sarokhalil
    Antimicrobial Resistance & Infection Control, 13